Skip to main content
IXICO PLC logo

IXICO PLC — Investor Relations & Filings

Ticker · IXI ISIN · GB00BFXR4C20 LEI · 2138005M1F59O6HWSA97 IL Professional, scientific and technical activities
Open in API
Filings indexed 354 across all filing types
Latest filing 2024-10-09 Capital/Financing Update
Country GB United Kingdom
Listing IL IXI

About IXICO PLC

https://www.ixico.com/

IXICO PLC is a clinical research and data analytics company specializing in neuroscience. It provides neuroimaging and digital biomarker analytics to biopharmaceutical firms conducting clinical trials for neurological disorders. The company utilizes its proprietary, AI-driven technology platform to manage and analyze complex imaging and digital health data. This platform deploys disease-specific algorithms to generate reliable clinical data and precision insights, aiming to accelerate research and development decision-making, de-risk clinical studies, and support the advancement of new therapies for conditions such as Alzheimer's and Huntington's disease.

Recent filings

Filing Released Lang Actions
Result of Placing and Subscription
Capital/Financing Update Classification · 1% confidence The document is an official announcement released via RNS (RNS Number: 4436H) on October 9, 2024. The content details the 'Result of Placing and Subscription,' announcing that the company conditionally raised gross proceeds of £4.0 million through a fundraising effort involving existing shareholders and directors (related party transactions). It also mentions the expectation of publishing a Shareholder Circular and holding a General Meeting. Since the document is an official regulatory announcement detailing a significant corporate action (fundraising/share issuance) and is distributed via the RNS system, it fits best under the general 'Regulatory Filings' category, as it is not a specific report like 10-K, ER, or IR. While it relates to capital changes (CAP), the primary nature here is the regulatory dissemination of the result of that action via the official news service.
2024-10-09 English
Retail Offer
Regulatory Filings Classification · 1% confidence The document is an official announcement dated October 8, 2024, originating from IXICO plc, identified by the RNS Number 4164H. The text explicitly announces a 'Retail Offer to raise up to £0.25 million via Bookbuild Platform' and details the issue price, the number of new ordinary shares, and the expected timetable for the offer and admission. This clearly describes a corporate action related to raising capital through the issuance of new shares, specifically targeting retail shareholders as part of a larger fundraising effort (which also includes a Placing and Subscription). This aligns directly with the definition of 'Capital/Financing Update' (CAP). Although it is an announcement, it is the primary document detailing the financing terms, making CAP more specific than a general RPA or RNS.
2024-10-08 English
Placing and Subscription
Capital/Financing Update Classification · 1% confidence The document is an official announcement released via RNS (RNS Number : 4163H) on October 8, 2024. The content explicitly details a plan to raise capital through a 'Placing and Subscription' and a 'Retail Offer' involving the issuance of new ordinary shares at a specific price (9.5 pence per share). It also mentions a 'Notice of General Meeting' required to approve the fundraising. This clearly falls under corporate financing activities. The most specific category for fundraising/capital structure changes is 'Capital/Financing Update' (CAP). Although it is an RNS announcement, the core subject matter is the capital raise, making CAP more precise than the general RNS fallback. The document is substantial (over 135k characters), indicating it is the primary announcement, not just a brief notice of publication.
2024-10-08 English
Trading Update
Earnings Release Classification · 1% confidence The document is a short announcement (4572 characters) released via RNS (Regulatory News Service) on August 14, 2024. It is titled 'Trading update for the year ending 30 September 2024' and provides key financial highlights (expected revenue, order book, cash, EBITDA) for the upcoming fiscal year, comparing them to previous periods and market expectations. This content structure—a brief update on recent performance and outlook, often preceding a full report—fits the definition of an Earnings Release (ER). However, since it is explicitly distributed through RNS and is a concise update rather than a comprehensive quarterly report (IR) or annual report (10-K), and given the nature of the RNS distribution system, it strongly aligns with a general regulatory announcement or a specific type of earnings announcement. Given the options, 'ER' (Earnings Release) is the most specific fit for a trading update containing financial expectations. If it were merely announcing the release of a full report, RPA would apply, but this document contains the actual performance summary. FY 2024
2024-08-14 English
Contract Win
Regulatory Filings Classification · 1% confidence The document starts with an 'RNS Number' and is dated, indicating it is a regulatory announcement from the London Stock Exchange's news service (RNS). The content announces a specific business event: a long-term contract win for a clinical trial. This type of material announcement, which is not a full financial report (like 10-K or IR), a dividend notice, or a management change, fits best under the general category for regulatory announcements that do not fit elsewhere, which is RNS (Regulatory Filings). Given the short length (3919 chars) and the nature of announcing a specific business development, RNS is the most appropriate classification.
2024-08-14 English
Board Appointment
Board/Management Information Classification · 1% confidence The document is a formal announcement released via RNS (RNS Number: 0599Z) on August 5, 2024. The core content is the 'Appointment of CEO,' detailing the incoming CEO (Bram Goorden) and the outgoing CEO (Giulio Cerroni). This directly relates to changes in senior management. According to the definitions, 'Board/Management Information' (Code: MANG) covers the 'Announcement of changes in the company's board of directors or senior management.' Although it is distributed via RNS, the specific content is a management change, making MANG the most precise classification over the general RNS fallback.
2024-08-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.